Hongtao Liu
University of Wisconsin, Madison · UW Carbone Cancer Center · The First Affiliated Hospital of USTC, University of Science and Technology of China
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hongtao Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:26 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07909733 · Maintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allo-SCTUniversity of Wisconsin, Madison · not yet recruiting · High-risk Myeloid Malignancy, Allogenic Stem Cell Transplantation, Acute Myeloid Leukemia (AML) · principal investigator
- N/ANCT07285668 · Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic MalignanciesUniversity of Wisconsin, Madison · recruiting · Hematologic Malignancies · principal investigator
- N/ANCT04562051 · Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- RecipientsWest China Hospital · unknown · Kidney Transplantation, HBV · principal investigator
- Ph1NCT02985554 · Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic MalignanciesUniversity of Chicago · terminated · Hematologic Malignancies · principal investigator
- Ph1NCT02573363 · Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid LeukemiaUniversity of Chicago · completed · Acute Myeloid Leukemia · principal investigator
- Ph1NCT02485535 · Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After TransplantUniversity of Chicago · completed · Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome · principal investigator
- Ph1NCT02333162 · Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantUniversity of Chicago · suspended · Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia · principal investigator
- Ph1NCT01842139 · Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete RemissionUniversity of Chicago · completed · Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) · principal investigator
- Ph2NCT01839916 · Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesUniversity of Chicago · completed · Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) · principal investigator
- N/ANCT00943800 · Combined Haploidentical-Cord Blood Transplantation for Adults and ChildrenUniversity of Chicago · completed · Leukemia, Myelodysplastic Syndrome, Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Clinical and Experimental TherapeuticsP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI Wendy Stock · fiscal years 2010 to 2026
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 12:26 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.Blood Adv · 2020184 citationsRCR 7.5
- 143 citationsRCR 3.6
- CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.Lancet Haematol · 2021123 citationsRCR 6.5
- Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.Leukemia · 201074 citationsRCR 1.8
- Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center.Blood Cancer J · 202158 citationsRCR 2.9
- Triple intrathecal therapy alone with omission of cranial radiation in children with acute lymphoblastic leukemia.J Clin Oncol · 201435 citationsRCR 1.0
- 29 citationsRCR 1.3
- Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia.Leuk Res · 201825 citationsRCR 1.1
- Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation.Pediatr Blood Cancer · 201720 citationsRCR 0.6
- Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia.Pediatr Blood Cancer · 201820 citationsRCR 0.6